Ledger.Open graph →
SEC Form D · Amendment · filed June 27, 2017

KinDex Pharmaceuticals, Inc

Offering
$1.3M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Jeffrey J. Katke · Seattle, WADirectorJeffrey S. Bland · Seattle, WAExec · DirectorNeile A. Grayson · Seattle, WAExecLincoln J. Bouillon · Seattle, WAExecMichael J. Higgins · Seattle, WADirectorPaul J. Schimmel · Seattle, WADirectorDennis A. Ausiello · Seattle, WADirectorBetsy Biemann · Brunswick, MEDirectorBrent S. Eck · Seattle, WADirectorVerne O. Sedlacek · WILTON, CTExecJohn W. Auchincloss · WILTON, CTExec · DirectorA. N. De Monico · WILTON, CTExecJames T. Hickey · Houston, TXDirectorJay T. Jackson · Houston, TXDirectorKyle J. Cunningham · Glen Mills, PADirectorDennis A. Ausiello · Seattle, WADirectorBrent S. Eck · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗